Homebuilder (NYSE:DHI) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 15.1% year on year to $7.73 billion. The company’s full-year revenue guidance of $34.05 billion at the midpoint came in 5.8% below analysts’ estimates. Its GAAP profit of $2.58 per share was 2.5% below analysts’ consensus estimates.
Known for his philosophy of investing in what you know, Peter Lynch looked for companies with consistent earnings growth, low debt, and a competitive edge. Does DR HORTON INC (NYSE:DHI) meet these key criteria? Let’s find out.
D.R. Horton’s stock price has taken a beating over the past six months, shedding 34.4% of its value and falling to a new 52-week low of $125.20 per share. This may have investors wondering how to approach the situation.
Lynch encouraged investors to look at businesses they understand and have strong financials. Does DR HORTON INC (NYSE:DHI) align with this approach? We take a closer look.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at D.R. Horton (NYSE:DHI) and its peers.
Headlines of dividend increases can permeate at a dazzling pace during the meatiest weeks of earnings season. However, late-reporting stragglers also deserve recognition for their willingness to return more capital to shareholders.
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer.
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
